Principles for the use of in vivo transgene techniques: Overview and an introductory practical guide for the selection of tetracycline-controlled transgenic mice

Methods in Molecular Biology

Volumn 1142, Issue , 2014, Pages 33-40

  Sakai, Norio ^a  

^a NONE

Author keywords

Gene silencing; Tet off system; Tet on system; Tetracycline controlled system; Transgenic mice

Indexed keywords

TETRACYCLINE; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA BINDING; GENE PRODUCT; GENE SILENCING; GENE TARGETING; GENETIC PROCEDURES; HUMAN; MEDICAL INFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SILENCER ELEMENT; TETRACYCLINE CONTROLLED TRANSGENIC MOUSE; TIME; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; DRUG EFFECT; GENETIC ENGINEERING; GENETICS; METHODOLOGY; REVIEW;

ANIMALS; GENE SILENCING; GENETIC ENGINEERING; MICE; MICE, TRANSGENIC; PROTEINS; TETRACYCLINE; TRANSCRIPTIONAL ACTIVATION; TRANSGENES;

EID: 84910008365     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0404-4_4     Document Type: Article

References (11)

1. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547–5551
2. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766–1769
3. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 97:7963–7968
4. Freundlieb S, Schirra-Muller C, Bujard H (1999) A tetracycline controlled activation/ repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1:4–12
5. Huettner CS, Koschmieder S, Iwasaki H, Iwasaki-Arai J, Radomska HS, Akashi K et al (2003) Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood 102:3363–3370
6. Kharas MG, Yusuf I, Scarfone VM, Yang VW, Segre JA, Huettner CS et al (2007) KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood 109:747–755
7. Bockamp E, Antunes C, Maringer M, Heck R, Presser K, Beilke S et al (2006) Tetracyclinecontrolled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kitexpressing lineage-negative hematopoietic cells. Blood 108:1533–1541
8. Huai J, Firat E, Niedermann G (2007) Inducible gene expression with the Tet-on system in CD4+ T cells and thymocytes of mice. Genesis 45:427–431
9. Rahim MM, Chrobak P, Hu C, Hanna Z, Jolicoeur P (2009) Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphopenia. J Virol 83:11830–11846
10. Pillai MM, Hayes B, Torok-Storb B (2009) Inducible transgenes under the control of the hCD68 promoter identifies mouse macrophages with a distribution that differs from the F4/80 –and CSF-1R-expressing populations. Exp Hematol 37:1387–1392
11. Peng J, Bencsik M, Louie A, Lu W, Millard S, Nguyen P et al (2008) Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinology 149: 1329–1337